Reema Mody
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Gastroesophageal reflux and treatments, Diabetes Treatment and Management, Eosinophilic Esophagitis, Inflammatory Bowel Disease, Microscopic Colitis
Most-Cited Works
- → Long-term Efficacy of Vedolizumab for Ulcerative Colitis(2016)221 cited
- → Long-term Efficacy of Vedolizumab for Crohn’s Disease(2016)214 cited
- → Impact of Chronic Constipation on Health-Related Quality of Life, Work Productivity, and Healthcare Resource Use: An Analysis of the National Health and Wellness Survey(2011)209 cited
- → Cumulative cost pattern comparison of prostate cancer treatments(2006)129 cited
- → Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation(2014)117 cited
- → Disease-Related and All-Cause Health Care Costs of Elderly Patients With Gout(2008)112 cited
- → Effects of Gastroesophageal Reflux Disease on Sleep and Outcomes(2009)107 cited
- → Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon‐like peptide‐1 receptor agonists: H igher adherence and persistence with dulaglutide compared with once‐weekly exenatide and liraglutide(2017)106 cited
- → The Effect of Serum Urate on Gout Flares and Their Associated Costs(2009)106 cited
- → Systematic Review with Network Meta-Analysis: Comparative Efficacy of Biologics in the Treatment of Moderately to Severely Active Ulcerative Colitis(2016)100 cited